Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
LY ›
LYNXZIMO
Trademark search for:
LYNXZIMO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-11-10 — Application filed
2016-11-14 — Application filed
2016-11-16 — Application filed
2016-12-27 — Assigned to examiner
2016-12-29 — Letter of suspension e-mailed
2016-12-29 — Notification of letter of suspension e-mailed
2016-12-29 — Suspension letter written
2017-01-12 — Teas response to suspension inquiry received
2017-01-31 — Assigned to lie
2017-02-08 — Correspondence received in law office
2017-02-08 — Teas/email correspondence entered
2017-02-21 — Approved for pub - principal register
2017-02-28 — Law office publication review completed
2017-03-15 — Notification of notice of publication e-mailed
2017-04-04 — Published for opposition
2017-04-04 — Official gazette publication confirmation e-mailed
2017-05-30 — Noa e-mailed - sou required from applicant
2017-06-13 — Notice of allowance cancelled
2017-06-13 — Teas delete 1(b) basis received
2017-06-30 — Case assigned to intent to use paralegal
2017-06-30 — 1(b) basis deleted; proceed to registration
2017-08-08 — Registered-principal register
2022-08-08 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-02-23 — Cancelled sec. 8 (6-yr)
2024-02-23 — Final status recorded
Owner Information
Novartis AG
Novartis AG
Novartis AG
Correspondent
MAURY M. TEPPER, III TEPPER & EYSTER, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
